Huntington's disease-like 2

R. L. Margolis, D. D. Rudnicki

Research output: Chapter in Book/Report/Conference proceedingChapter

4 Scopus citations

Abstract

Huntington's disease like-2 (HDL2) is an autosomal dominant disorder that clinically and pathologically closely resembles Huntington's disease (HD). Like HD, HDL2 is characterized by mid-life onset, abnormalities of voluntary and involuntary movement, psychiatric syndromes, and dementia, with a relentless progress to death. The disease is rare, and thus far has only been detected in individuals of African ancestry. Striatal and cortical atrophy is prominent, as are intranuclear protein aggregates. Some, but not all, affected individuals have acanthocytosis. HDL2 is caused by a CAG/CTG expansion mutation on chromosome 16q24.3, in an alternatively spliced exon of junctophilin-3. The mechanism of HDL2 pathogenesis is uncertain, but may involve the toxic properties of mutant transcripts containing expanded CUG repeats.

Original languageEnglish (US)
Title of host publicationNeuroacanthocytosis Syndromes II
PublisherSpringer-Verlag Berlin Heidelberg
Pages59-73
Number of pages15
ISBN (Electronic)9783540716938
ISBN (Print)9783540716921
DOIs
StatePublished - Jan 1 2008

ASJC Scopus subject areas

  • General Medicine
  • General Neuroscience

Fingerprint

Dive into the research topics of 'Huntington's disease-like 2'. Together they form a unique fingerprint.

Cite this